Department of Surgery, Chan Medical School - Baystate Medical Center, University of Massachusetts, 759 Chestnut Street, Springfield, MA, 01199, USA.
Department of Surgery, Saint Francis Hospital and Medical Center, Hartford, CT, USA.
Surg Endosc. 2024 Sep;38(9):5331-5337. doi: 10.1007/s00464-024-11051-y. Epub 2024 Jul 18.
Achalasia is an esophageal motility disorder with three subtypes based on manometry that can treated with per-oral endoscopic myotomy (POEM). With the advent of impedance planimetry (EndoFLIP®), we hypothesized the three achalasia subtypes would have different pre-POEM EndoFLIP® diameter and distensibility index (DI) measurements but would be similar after POEM.
A single-institution, retrospective review of consecutive POEM cases by a single surgeon-endoscopist team from 04/07/2017 to 08/28/2023. Patients with a diagnosis of achalasia were stratified into type 1, 2, or 3 based on pre-POEM manometry. Patient characteristics, Eckardt scores, and pre-and-post-POEM diameter and DI were compared by subtype with descriptive, univariate, and multivariable linear regression statistics.
Sixty-four patients met inclusion criteria, of whom 9(14.1%) had Type 1, 36(56.3%) had Type 2, and 19(29.7%) had Type 3. There were no differences between Types with respect to median pre-POEM Eckardt scores (9[IQR:7-9) vs. 8[IQR:6-9] vs. 7[IQR:5-8], p = 0.148), median post-POEM Eckardt scores (0[IQR:0-1] vs. 0[IQR:0-0] vs. 0[IQR0-0.5], p = 0.112). EndoFLIP® data revealed variation in median pre-POEM diameter and DI between Subtypes (6.9[IQR:6-8.5] vs. 5.5[IQR:5-6.8] vs. 5[IQR:5-6.1], p = 0.025 and 1.8[IQR:1.3-3.2] vs. 0.9[IQR:0.6-1.6] vs. 0.6[IQR:0.5-0.8], p = 0.003, respectively), but not in the change in diameter or DI post-POEM (5.1[IQR:4.3-5.9] vs. 5.1[IQR:4.1-7.1] vs. 5.9[IQR:5-6.4], p = 0.217 and 3.9[IQR:2.5-4.7] vs. 3.4[IQR:2.4-4.7] vs. 2.7[IQR:2.3-3.7], p = 0.461, respectively). However, after adjusting for potentially confounding factors, pre- or post-POEM diameter and DI did not demonstrate statistically significant differences among subtypes.
Achalasia subtypes did not demonstrate different pre-POEM diameters or DI as measured by EndoFLIP® nor are there differences after POEM completion. While achalasia subtypes may have slightly different pathophysiology based on manometry findings, similar pre- and post-POEM impedance planimetry findings, along with similar Eckardt scores, support the use of POEM in the treatment of any achalasia subtype.
贲门失弛缓症是一种基于测压的食管运动障碍,可通过经口内镜肌切开术(POEM)进行治疗。随着阻抗平面测量法(EndoFLIP®)的出现,我们假设贲门失弛缓症的三个亚型在术前 EndoFLIP®直径和扩张指数(DI)测量方面存在差异,但在 POEM 后会相似。
这是一项单中心、回顾性研究,纳入了 2017 年 4 月 7 日至 2023 年 8 月 28 日期间由同一位外科内镜医生团队进行的连续 POEM 病例。根据术前测压结果将贲门失弛缓症患者分为 1 型、2 型或 3 型。通过描述性、单变量和多变量线性回归统计方法比较亚型间患者特征、Eckardt 评分以及术前和术后直径和 DI 的差异。
64 例患者符合纳入标准,其中 9 例(14.1%)为 1 型,36 例(56.3%)为 2 型,19 例(29.7%)为 3 型。在术前 Eckardt 评分中位数方面,各亚型间无差异(9[IQR:7-9] vs. 8[IQR:6-9] vs. 7[IQR:5-8],p=0.148),术后 Eckardt 评分中位数亦无差异(0[IQR:0-1] vs. 0[IQR:0-0] vs. 0[IQR0-0.5],p=0.112)。EndoFLIP®数据显示,各亚型间术前直径和 DI 中位数存在差异(6.9[IQR:6-8.5] vs. 5.5[IQR:5-6.8] vs. 5[IQR:5-6.1],p=0.025 和 1.8[IQR:1.3-3.2] vs. 0.9[IQR:0.6-1.6] vs. 0.6[IQR:0.5-0.8],p=0.003),但术后直径和 DI 变化无差异(5.1[IQR:4.3-5.9] vs. 5.1[IQR:4.1-7.1] vs. 5.9[IQR:5-6.4],p=0.217 和 3.9[IQR:2.5-4.7] vs. 3.4[IQR:2.4-4.7] vs. 2.7[IQR:2.3-3.7],p=0.461)。然而,在调整潜在混杂因素后,亚型间术前和术后直径和 DI 无统计学差异。
根据 EndoFLIP®测量,贲门失弛缓症各亚型间术前直径和 DI 无差异,POEM 术后亦无差异。虽然基于测压结果贲门失弛缓症各亚型的病理生理学可能略有不同,但相似的术前和术后阻抗平面测量结果,以及相似的 Eckardt 评分,支持使用 POEM 治疗任何亚型的贲门失弛缓症。